TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice
Samera H. Hamad, Stephanie A. Montgomery, Jeremy M. Simon, Brittany M. Bowman, Kyle B. Spainhower, Ryan M. Murphy, Erik S. Knudsen, Suzanne E. Fenton, Scott H. Randell, Jeremiah Holt, D. Neil Hayes, Agnieszka K. Witkiewicz, Trudy G. Oliver, Michael B. Major, Bernard E. Weissman
Topics & Concepts
BiologyCDKN2ACancer researchLung cancerCarcinogenesisSmall Cell Lung CarcinomaImmunohistochemistryCancerMutationCarcinomaPathologySmall-cell carcinomaGeneImmunologyGeneticsMedicineLung Cancer Research StudiesEpigenetics and DNA MethylationRNA modifications and cancer